[1]
V. Shahabi Raberi, A. Shariati, M. Abbasnezhad, N. Aslanabadi, A. Abbasnezhad, and A. Bahmani, “Drug Resistance and Cardiovascular Safety of Second-Generation Anti-Androgens in Patients with Advanced Prostate Cancer”, Galen Med J, vol. 11, p. e2727, Dec. 2022.